儿童葡萄膜炎并发白内障的危险因素
该队列研究纳入140例葡萄膜炎患儿的247只眼,评估视力受影响白内障的发生情况,发现白内障患病率为44.2%,全葡萄膜炎眼最高(77.1%),每年葡萄膜炎发作次数、黄斑囊样水肿、初诊时虹膜后粘连及局部注射糖皮质激素是白内障发生的危险因素。
要点
- 儿童葡萄膜炎眼白内障患病率为44.2%,全葡萄膜炎眼最高(77.1%)。
- 每年葡萄膜炎发作次数(HR=3.06)、黄斑囊样水肿(HR=2.87)、初诊虹膜后粘连(HR=2.85)及局部注射糖皮质激素(HR=2.37)与白内障发生相关。
- 全身及局部滴用糖皮质激素并非显著危险因素,作者建议控制炎症以预防白内障等眼部并发症。
核心结论
- 儿童葡萄膜炎眼白内障常见,与炎症复发程度和眼部并发症关系最强。
- 作者建议控制炎症,即使使用较高剂量的全身和局部糖皮质激素,对预防白内障等眼部并发症具有重要意义。
研究设计与样本
- 队列研究,纳入140例葡萄膜炎患儿的247只眼,评估视力受影响白内障的发生。
- 收集从就诊至首次记录白内障或末次随访时的 demographic、临床和治疗数据。
主要发现
- 白内障患病率为44.2%,全葡萄膜炎眼为77.1%,慢性前葡萄膜炎眼为48.3%,中间葡萄膜炎眼为48.0%。
- 新诊断白内障的总体发生率为每眼年0.09,估计随时间69%的患眼会发生葡萄膜炎相关白内障。
- 每年葡萄膜炎发作次数与白内障发生相关(HR=3.06,95%CI 2.15-4.35,P<.001)。
- 黄斑囊样水肿(HR=2.87,95%CI 1.41-5.82,P=.004)、初诊时虹膜后粘连(HR=2.85,95%CI 1.53-5.30,P=.001)及局部注射糖皮质激素(HR=2.37,95%CI 1.18-4.75,P=.02)与白内障发生相关。
- 全身和局部滴用糖皮质激素治疗并非显著危险因素。
临床怎么用
- 作者建议控制炎症,即使使用较高剂量的全身和局部糖皮质激素,对预防白内障等眼部并发症具有重要意义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the risk factors for the development of cataract in children with uveitis of any etiology. DESIGN: Cohort study. METHODS: Two hundred forty-seven eyes of 140 children with uveitis were evaluated for the development of vision-affecting cataract. Demographic, clinical, and treatment data were collected between the time of presentation and the first instance cataract was recorded or findings at final follow-up. Main outcome measures included the prevalence of cataract and distribution by type of uveitis, incidence of new onset cataract time to cataract development, and risk factors for the development of cataract. RESULTS: The prevalence of cataract in our cohort was 44.2% and was highest among eyes with panuveitis (77.1%), chronic anterior uveitis (48.3%), and intermediate uveitis (48.0%). The overall incidence of newly diagnosed cataract was 0.09 per eye-year, with an estimated 69% to develop uveitis-related cataract with time. The main factors related with cataract development were the number of uveitis flares per year (hazard ratio [HR] = 3.06 [95% confidence interval {CI}, 2.15-4.35], P < .001), cystoid macular edema (HR = 2.87 [95% CI, 1.41-5.82], P = .004), posterior synechia at presentation (HR = 2.85 [95% CI, 1.53-5.30], P = .001), and use of local injections of corticosteroids (HR = 2.37 [95% CI, 1.18-4.75], P = .02). Treatments with systemic and topical corticosteroids were not significant risk factors. CONCLUSIONS: In this study, we found that development of cataract is common among pediatric eyes with uveitis and is most strongly related to the extent of inflammation recurrences and ocular complications. We suggest that controlling the inflammation, even using higher doses of systemic and topical corticosteroids, is of importance in preventing ocular complications, such as cataract.
引用
- Blum-Hareuveni T, Seguin-Greenstein S, Kramer M, et al. Risk Factors for the Development of Cataract in Children with Uveitis. Am J Ophthalmol. 2017. PMID: 28257832. doi:10.1016/j.ajo.2017.02.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。